Total planned funding: $268,726,449
Allocations
Countries/Regions
Eswatini | $268,726,449 |
Organizational Types
Private Contractor | $82,354,294 |
University | $52,549,839 |
NGO | $48,699,759 |
Own Agency | $32,921,185 |
Unknown | $24,201,779 |
Multi-lateral Agency | $9,554,780 |
FBO | $8,611,975 |
Host Country Government Agency | $8,395,539 |
Other USG Agency | $1,410,468 |
Implementing Agency | $26,831 |
Program Areas
Care | $89,107,632 |
Treatment | $72,245,051 |
Prevention | $43,740,514 |
Governance and Systems | $24,859,257 |
Testing | $22,224,660 |
Management and Operations | $16,549,335 |
Budget Codes
HTXS: Treatment: Adult Treatment | $51,619,538 |
HBHC: Care: Adult Care and Support | $41,032,983 |
HKID: Care: Orphans and Vulnerable Children | $28,727,686 |
HVCT: Testing: HIV Testing and Counseling | $22,224,660 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,622,142 |
HVMS: Management and Operations | $16,549,335 |
HTXD: Treatment: ARV Drugs | $15,816,298 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,184,146 |
HVTB: Care: TB/HIV | $11,509,741 |
OHSS: Health Systems Strengthening | $11,495,829 |
HVSI: Strategic Information | $9,685,135 |
PDCS: Care: Pediatric Care and Support | $7,837,222 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,369,028 |
PDTX: Treatment: Pediatric Treatment | $4,809,215 |
HLAB: Laboratory Infrastructure | $3,678,293 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,675,227 |
HMBL: Biomedical Prevention: Blood Safety | $889,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$44,226,997
Countries/Regions
Pact, Inc.:
$30,079,701
Countries/Regions
Not Available:
$19,802,793
Countries/Regions
USG Aggregated Agencies:
$19,710,433
Countries/Regions